Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Christopher W. Cain currently holds 37,313 shares of Cogent Biosciences, Inc. (COGT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher W. Cain has been a net neutral trader of COGT stock. They have purchased $0 and sold $0 worth of shares.
Christopher W. Cain's most recent insider trade was on Mar 23, 2026, when they sold 37,313 shares at $0.00 per share.
Christopher W. Cain serves as Executive at Cogent Biosciences, Inc. (COGT). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Christopher W. Cain holds the position of Executive at Cogent Biosciences, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Christopher W. Cain has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Christopher W. Cain was on Mar 23, 2026, when they purchased $0 worth of DMRA shares. This transaction involved 37,313 shares at N/A per share.
Christopher W. Cain currently owns 37,313 shares of Cogent Biosciences, Inc. (COGT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Christopher W. Cain's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Christopher W. Cain has 2 Form 4 filings on record as an insider at Cogent Biosciences, Inc..
Set alerts for Christopher W. Cain and 40,000+ other insiders.